MA
India’s Piramal at centre of buy-out speculation
February 9, 2009Sales and Marketing MA, Piramal
Indian pharmaceutical company Piramal has denied that it ready to sell up to one of the global giants of the …
Crucell linked with new takeover suitors
January 29, 2009Sales and Marketing Crucell, MA
Dutch vaccines firm Crucell could be snapped up by other pharmaceutical companies after Wyeth pulled out of negotiations to buy …
Pfizer unveils $68 billion takeover of Wyeth
January 26, 2009Sales and Marketing MA, Pfizer
Pfizer has unveiled a deal to acquire Wyeth for $68 billion, creating a new giant in pharmaceuticals, biotech, vaccines, consumer …
Pfizer to make merger bid for Wyeth
January 26, 2009Sales and Marketing MA, Pfizer
Pfizer looks set to make a multi-billion dollar takeover of fellow US pharma company Wyeth.The world's largest pharma company, Pfizer …
Amgen could be Pfizer takeover target
December 18, 2008Sales and Marketing Amgen, MA, Pfizer
Pfizer could be preparing itself to buy Amgen to maintain its lead in the sector, according to a leading analyst. …
GSK to acquire Hepatitis C specialists Genelabs
October 30, 2008Sales and Marketing GSK, Genelabs, MA
GlaxoSmithKline is to pay $57 million (£35 million) for Genelabs, California-based specialists in infectious diseases, including hepatitis C. The companies …
Lilly eyes oncology focus with ImClone acquisition
October 9, 2008Sales and Marketing Cancer, MA, lilly
Lilly is to buy ImClone for $6.5 billion after outbidding Bristol-Myers Squibb for the biotech company. Lilly says the acquisition …
Sanofi seals Zentiva deal with improved offer
September 23, 2008Sales and Marketing MA, Sanofi, generics
Sanofi-Aventis' acquisition of Czech generics firm Zentiva is back on, after the pharma company increased its offer by nearly 10%. …
Shire to buy up German biotech
July 3, 2008Sales and Marketing MA, biotech
Shire is set to acquire German biotech firm Jerini, in a bid to expand its portfolio of treatments for rare …
Roche to buy Piramed
April 15, 2008Sales and Marketing MA, Piramed
Roche is set to pay $160 million (£315 million) to buy UK biotech company Piramed, a move which will further …
Latest content
Acumetis CEO Herspiegel steps down as Burden assumes role
